Category: SARS
HHC News - INTRODUCING NEW PROtrol SARS Cov-2 ISOLATE - 13 APRIL 2023

Post Views: 539
Post Views: 539
HHC News - SARS CoV-2 LINEAGE BA.2.3 OMICRON VARIANT - 03 NOVEMBER 2022

Post Views: 1,267
Post Views: 1,267
HHC News - SARS-COV-2 INVENTORY - 30 SEPTEMBER 2022

Post Views: 721
Post Views: 721
Tags: blood products
Monoclonal Antibody Therapy for COVID-19

Post Views: 915 Monoclonal antibodies are laboratory-created proteins that replicate the immune system’s capacity to combat diseases such as SARS-CoV-2. Furthermore, SARS-CoV-2, like other infectious organisms, can change over time, resulting in specific therapies failing to act against particular variations, such as the Omicron. Monoclonal antibodies are medicinal agents being researched to treat COVID-19. These…
Post Views: 915